Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Publication year range
1.
Tex Heart Inst J ; 49(2)2022 03 01.
Article in English | MEDLINE | ID: mdl-35395088

ABSTRACT

Patients with left ventricular noncompaction (LVNC) are at risk of clinically significant arrhythmias and sudden death. We evaluated whether implantable loop recorders could detect significant arrhythmias that might be missed in these patients during annual Holter monitoring. Selected pediatric and adult patients with LVNC who consented to implantable loop recorder placement were monitored for 3 years (study duration, 10 April 2014-9 December 2019). Fourteen subjects were included (age range, 6.5-36.4 yr; 8 males). Of 13 patients who remained after one device extrusion, one underwent implantable cardioverter-defibrillator placement. Four patients (31%) had significant arrhythmias: atrial tachycardia (n=2), nonsustained ventricular tachycardia (n=1), and atrial fibrillation (n=1). All 4 events were clinically asymptomatic and not associated with left ventricular ejection fraction. In addition, a high frequency of benign arrhythmic patterns was detected. Implantable loop recorders enable continuous, long-term detection of important subclinical arrhythmias in selected patients who have LVNC. These devices may prove to be most valuable in patients who have LVNC and moderate or greater ventricular dysfunction.


Subject(s)
Atrial Fibrillation , Defibrillators, Implantable , Heart Defects, Congenital , Tachycardia, Ventricular , Adolescent , Adult , Atrial Fibrillation/diagnosis , Child , Electrocardiography, Ambulatory , Humans , Male , Stroke Volume , Tachycardia, Ventricular/diagnosis , Tachycardia, Ventricular/etiology , Tachycardia, Ventricular/therapy , Ventricular Function, Left , Young Adult
2.
Tex Heart Inst J ; 46(3): 203-206, 2019 Jun.
Article in English | MEDLINE | ID: mdl-31708704

ABSTRACT

The platelet aggregation inhibitor ticagrelor, a P2Y12 receptor antagonist, is widely used after angioplasty in patients with acute coronary syndrome. Clinical trial data have shown that it is well tolerated by most patients. We present the case of a 62-year-old woman whose ticagrelor-related asymptomatic and persistent sinus pauses after angioplasty resolved when ticagrelor was replaced with prasugrel.


Subject(s)
Acute Coronary Syndrome/surgery , Angioplasty, Balloon, Coronary/methods , Heart Arrest/chemically induced , Postoperative Complications , Ticagrelor/adverse effects , Acute Coronary Syndrome/drug therapy , Electrocardiography , Female , Heart Arrest/diagnosis , Humans , Middle Aged , Purinergic P2Y Receptor Antagonists/adverse effects
3.
Rev. colomb. cardiol ; 25(3): 176-184, mayo-jun. 2018. tab, graf
Article in Spanish | LILACS, COLNAL | ID: biblio-978223

ABSTRACT

Resumen Objetivos: Dar a conocer la experiencia clínica con un nuevo sistema de monitorización cardiaca extendida (por 15 días), inalámbrica y satelital en un grupo de pacientes con sospecha de arritmias cardíacas. Metodología: Cohorte de 100 pacientes atendidos en la unidad de Electrofisiología cardiovascular de un centro de referencia, con sospecha de arritmia cardíaca, sin diagnóstico electrocardiográfico causal, a pesar de exámenes previos. Se les aplicó una monitorización cardiaca externa tipo SEEQ (Medtronic) por 15 días y se registró el desenlace. Resultados: De un total de 100 sujetos estudiados, 51% eran hombres, con mediana de edad de 60 años (rango: 5 - 91 años). El principal síntoma fueron las palpitaciones (42%) y la comorbilidad más prevalente la hipertensión arterial (47%); 98% tenían estudio de Holter previo y 46% dos estudios sin resultado conclusivo que explicara los síntomas. La monitorización tipo SEEQ documentó anormalidad electrocardiográfica significativa en 22% de los pacientes. El implante de marcapaso fue el tratamiento más aplicado y la fibrilación auricular fue la arritmia más frecuente en el 50% de los hallazgos positivos. Hubo una proporción mayor y significativa de diagnósticos positivos en el sexo masculino. Conclusiones: La monitorización cardiaca externa inalámbrica, satelital, extendida por 15 días es una herramienta novedosa que incrementa la probabilidad de documentar una anormalidad electrocardiográfica clínicamente significativa en quienes padecen síntomas cardiovasculares recurrentes.


Abstract Objectives: To present the clinical experience with a new extended (for 15 days), wireless, and satellite cardiac monitoring system in a group of patients with suspicion of cardiac arrhythmia. Method: The study included a cohort of 100 patients seen in the Cardiovascular Electrophysiology Unit of a reference hospital. They were suspected of having a cardiac arrhythmia, with no electrocardiographic diagnosis of the cause, despite previous examinations. They were subjected to SEEQ-type (Medtronic) external cardiac monitoring for 15 days, with the outcomes recorded. Results: Of the total of 100 subjects studied, 51% were male, and the median age was 60 years (range: 5 - 91 years). The main symptoms were palpitation, and the most prevalent comorbidity was arterial hypertension (47%). Almost all (98%) of them had a previous Holter study, and 46% had two studies, which were inconclusive in explaining the symptoms. The SEEQ monitoring recorded a significant electrocardiographic abnormality in 22% of the patients. A pacemaker implant was the treatment most applied and atrial fibrillation was the most frequent arrhythmia in 50% of the positive findings. There was a higher and significant percentage of positive diagnoses in males. Conclusions: External, satellite, wireless cardiac monitoring extended for 15 days, is a novel tool that can increase the probability of documenting a clinically significant electrocardiographic abnormality in those patients who suffer recurrent cardiovascular symptoms.


Subject(s)
Humans , Male , Middle Aged , Arrhythmias, Cardiac/diagnosis , Electrocardiography, Ambulatory , Cardiac Electrophysiology , Hypertension
4.
Tex Heart Inst J ; 42(4): 381-4, 2015 Aug.
Article in English | MEDLINE | ID: mdl-26413024

ABSTRACT

ST-segment-elevation myocardial infarction is a leading cause of cardiovascular morbidity and death. We describe the case of a 51-year-old woman with advanced adenocarcinoma of the lung who presented with ST-segment elevation in the presence of an extracardiac lung mass but no objective evidence of myocardial ischemia or pericardial involvement. After the patient died of hypoxic respiratory failure, autopsy findings confirmed normal-appearing pericardium and myocardium, and mild-to-moderate atherosclerosis in the coronary arteries. A 4.5 × 4-cm extracardiac left hilar lung mass was confirmed to be poorly differentiated adenocarcinoma of the lung adjacent to the myocardium. The persistent current of injury that had been detected electrocardiographically was thought to occur from direct myocardial compression. ST-segment elevations secondary to direct mass contact on the myocardium should be considered in patients who have a malignancy and ST-segment elevation.


Subject(s)
Adenocarcinoma/complications , Arrhythmias, Cardiac/etiology , Lung Neoplasms/complications , Adenocarcinoma/pathology , Adenocarcinoma/therapy , Adenocarcinoma of Lung , Arrhythmias, Cardiac/diagnosis , Autopsy , Diagnosis, Differential , Electrocardiography , Fatal Outcome , Female , Humans , Lung Neoplasms/pathology , Lung Neoplasms/therapy , Middle Aged , Myocardial Infarction/diagnosis , Positron-Emission Tomography , Predictive Value of Tests , Tomography, X-Ray Computed
5.
Tex Heart Inst J ; 41(6): 620-5, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25593527

ABSTRACT

Cardiac tumors can lead to distinct electrocardiographic changes and ventricular arrhythmias. Benign and malignant cardiac tumors have been associated with ventricular tachycardia. When possible, benign tumors should be resected when ventricular arrhythmias are intractable. Chemotherapy can shrink malignant tumors and eliminate arrhythmias. We report the case of a 52-year-old woman with breast sarcoma whom we diagnosed with myocardial metastasis after she presented with palpitations. The initial electrocardiogram revealed sinus rhythm with new right bundle branch block and ST-segment elevation in the anterior precordial leads. During telemetry, hemodynamically stable, sustained ventricular tachycardia with right ventricular localization was detected. Images showed a myocardial mass in the right ventricular free wall. Amiodarone suppressed the arrhythmia. To our knowledge, this is the first report of ventricular tachycardia associated with radiation-induced undifferentiated sarcoma. We discuss the distinct electrocardiographic changes and ventricular arrhythmias that can be associated with cardiac tumors, and we review the relevant medical literature.


Subject(s)
Breast Neoplasms/radiotherapy , Heart Neoplasms/complications , Heart Rate , Neoplasms, Radiation-Induced/complications , Sarcoma/complications , Tachycardia, Ventricular/etiology , Amiodarone/therapeutic use , Anti-Arrhythmia Agents/therapeutic use , Echocardiography , Electrocardiography , Female , Heart Neoplasms/diagnosis , Heart Neoplasms/therapy , Heart Rate/drug effects , Humans , Middle Aged , Neoplasms, Radiation-Induced/diagnosis , Neoplasms, Radiation-Induced/therapy , Predictive Value of Tests , Radiotherapy/adverse effects , Sarcoma/diagnosis , Sarcoma/therapy , Tachycardia, Ventricular/diagnosis , Tachycardia, Ventricular/drug therapy , Tachycardia, Ventricular/physiopathology , Tomography, X-Ray Computed , Treatment Outcome
6.
Tex Heart Inst J ; 40(3): 347-9, 2013.
Article in English | MEDLINE | ID: mdl-23914037

ABSTRACT

Syncope is common in the general population. Despite extensive evaluation, including tilt-table testing and electrophysiologic studies, approximately 30% of cases of recurrent syncope remain unexplained. An implantable loop recorder can be used for diagnosis when recurrent syncope has an idiopathic cause. We present the case of a 9-year-old boy who had a history of recurrent, exercise-induced syncope. Results of physical examination and noninvasive diagnostic testing were inconclusive, and an electrophysiologic study revealed no inducible supraventricular or ventricular arrhythmias. Sixteen months after an implantable loop recorder was placed, the patient had a syncopal episode while swimming in a pool. Cardiopulmonary resuscitation was performed, and data from the loop recorder revealed polymorphic ventricular tachycardia and ventricular fibrillation. A cardioverter-defibrillator was subsequently implanted. Implantable loop recorders can play an important role in the diagnosis of life-threatening arrhythmias in children whose syncope is otherwise unexplained.


Subject(s)
Electrocardiography, Ambulatory/instrumentation , Exercise , Syncope/diagnosis , Tachycardia, Ventricular/diagnosis , Telemetry/instrumentation , Ventricular Fibrillation/diagnosis , Cardiopulmonary Resuscitation , Child , Defibrillators, Implantable , Electric Countershock/instrumentation , Equipment Design , Heart Rate , Humans , Male , Predictive Value of Tests , Recurrence , Syncope/etiology , Syncope/physiopathology , Syncope/therapy , Tachycardia, Ventricular/etiology , Tachycardia, Ventricular/physiopathology , Tachycardia, Ventricular/therapy , Treatment Outcome , Ventricular Fibrillation/etiology , Ventricular Fibrillation/physiopathology , Ventricular Fibrillation/therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...